Blood Pressure Medication Recalled Nationwide For Metal Risk

Prescription Medication Medicine Pill Tablets

Photo: EHStock / iStock / Getty Images

A lot of propranolol hydrochloride extended-release capsules—used to treat high blood pressure—has been recalled nationwide due to the risk of metal contamination, which could cause internal cuts. According to the recall announcement, Breckenridge Pharmaceutical, Inc. voluntarily recalled one lot of 60 mg propranolol hydrochloride extended-release capsules after discovering that the pills may contain metal fragments.

The affected capsules were distributed to wholesalers and pharmacies across the United States between October 26 and November 4. The recalled product is packaged in 100-count bottles, labeled with lot number PK25110035 and an expiration date of May 2029. The capsules are manufactured by Adare Pharma Solutions.

The company warned that anyone who takes the contaminated pills could suffer lacerations of soft tissues in the oral cavity, esophagus, stomach, or intestine. To date, Breckenridge Pharmaceutical said it is not aware of any reported injuries or adverse health events linked to the recalled medication.

Consumers who may have received the recalled capsules are advised to immediately stop taking the medicine and contact their doctor for guidance and a replacement, according to Gray News. Any unused capsules should be returned to the pharmacy where they were purchased. The company also instructed wholesalers, pharmacies, and retailers to check their inventories, set aside any affected products, and avoid further distribution.

Questions about the recall can be directed to Qualanex, the company's recall service provider, at 1-855-736-0807 or recall@qualanex.com, Monday through Friday, 9 a.m. to 5 p.m. Eastern Time. Adverse reactions or quality problems may be reported to the U.S. Food and Drug Administration’s MedWatch program. Breckenridge said the recall is being conducted with the FDA’s knowledge.